abstract |
The invention relates to a human monoclonal antibody that binds to an antigen of 4 cytotoxic T lymphocytes, a pharmaceutical composition comprising the antibody, a cell line producing the antibody, an isolated molecule that encodes a heavy or light chain of said antibody, a host cell comprising said isolated molecule; use of said antibody for the manufacture of a medicament for enhancing cytokine production in T cells. |